BTI
RMD icon

Blue Trust Inc’s ResMed RMD Stock Holding History

Blue Trust Inc’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55K Sell
282
-62
-18% -$12.8K ﹤0.01% 1310
2026
Q1 		$77.2K Sell
344
-118
-26% -$29.4K ﹤0.01% 1138
2025
Q4 		$111K Buy
462
+5
+1% +$1.28K ﹤0.01% 1004
2025
Q3 		$125K Sell
457
-19
-4% -$5.19K ﹤0.01% 978
2025
Q2 		$123K Sell
476
-215
-31% -$51.3K ﹤0.01% 962
2025
Q1 		$155K Buy
691
+239
+53% +$55.8K ﹤0.01% 809
2024
Q4 		$103K Sell
452
-522
-54% -$126K ﹤0.01% 928
2024
Q3 		$186K Buy
974
+762
+359% +$170K ﹤0.01% 896
2024
Q2 		$42K Buy
212
+137
+183% +$27.8K ﹤0.01% 1320
2024
Q1 		$14.9K Buy
75
+26
+53% +$4.76K ﹤0.01% 1335
2023
Q4 		$7K Sell
49
-88
-64% -$13.5K ﹤0.01% 1721
2023
Q3 		$30K Buy
137
+18
+15% +$3.25K ﹤0.01% 1039
2023
Q2 		$26K Sell
119
-95
-44% -$21.2K ﹤0.01% 952
2023
Q1 		$45K Buy
214
+55
+35% +$11.9K ﹤0.01% 1078
2022
Q4 		$35K Buy
159
+67
+73% +$14.7K ﹤0.01% 1075
2022
Q3 		$20K Buy
92
+7
+8% +$1.59K ﹤0.01% 1097
2022
Q2 		$21K Buy
+85
New +$18.1K ﹤0.01% 938

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Blue Trust Inc's RMD Position: Q2 2026 in Review

Blue Trust Inc reduced its ResMed (RMD) stake by 18% in Q2 2026, selling an estimated $12.8K and leaving 282 shares worth $55K. The position accounts for ﹤0.01% of the portfolio, ranked #1310.

Blue Trust Inc first reported a position in RMD in Q2 2022 and has held it in 17 quarters since. The position peaked at $186K in Q3 2024. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Blue Trust Inc held 282 shares of ResMed worth $55K as of Q2 2026.
  • Blue Trust Inc sold 62 ResMed shares in Q2 2026, an estimated $12.8K.
  • ResMed made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1310 holding.
  • Blue Trust Inc first reported a position in ResMed in Q2 2022 and has held it in 17 quarters since.
  • Blue Trust Inc's ResMed position peaked at $186K in Q3 2024.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.